References
- Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014;164(3):510–514.e1.
- Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1(4):CD010061
- Green K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by paracetamol. Prostaglandins. 1989;37(3):311–315.
- Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. 2018;19(7):e394–e402.
- Dani C, Poggi C, Mosca F, et al. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial. Trials. 2016;17(1):182.
- Dash SK, Kabra NS, Avasthi BS, et al. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatr. 2015;52(7):573–578.
- Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLOS One. 2013;8(11):e77888.
- Bagheri MM, Niknafs P, Sabsevari F, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran Pediatr. 2016;26(4):e3975.
- Mitra S, Florez ID, Tamayo ME, et al. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterminfants: a protocol for a systematic review and network meta-analysis. BMJ Open. 2016; 6(7):e011271.
- El-Mashad AE, El-Mahdy H, El Amrousy DE, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176(2):233–240.
- Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Exp Ther Med. 2016;12(4):2531–2536.
- El-Khuffash A, Jain A, Corcoran D, et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res. 2014;76(3):238–244.
- Harkin P, Harma A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr. 2016;177:72–77.e2.
- Dowd LA, Wheeler BJ, Al-Sallami HS, et al. Paracetamol treatment for patent ductus arteriosus: practice and attitudes in Australia and New Zealand. J Matern Fetal Neonatal Med. 2019;32(18):3039–3044.
- Yurttutan S, Oncel MY, Arayici S, et al. A different first choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med. 2013;26(8):825–827.
- Bardanzellu F, Neroni P, Dessì A, et al. Paracetamol in patent ductus arteriosus treatment: efficacious and safe?. Biomed Res Int. 2017;2017:1–25. DOI:https://doi.org/10.1155/2017/1438038
- Cook SF, Roberts JK, Samiee-Zafarghandy S, et al. Population pharmacokinetics of intravenous paracetamol (acetaminophen) in preterm and term neonates: model development and external evaluation. Clin Pharmacokinet. 2016;55(1):107–119.